Bioreactors and Fermenters Sales

Bioreactors and Fermenters Sales Market Outlook

The global bioreactors and fermenters sales market is projected to reach approximately USD 15 billion by 2035, growing at a remarkable CAGR of around 10% during the forecast period from 2025 to 2035. This growth can primarily be attributed to the increasing demand for biopharmaceuticals, advancements in fermentation technology, and the rising focus on sustainable practices in the food and beverage industry. Additionally, the growing prevalence of chronic diseases and the necessity for effective treatment options have driven research and development in bioprocessing technologies, leading to an uptick in bioreactor and fermenter sales. The burgeoning biotechnology sector has further fueled the need for sophisticated bioprocessing equipment, which is essential for producing a variety of biological products. Moreover, the trend toward personalized medicine and the demand for high-quality production processes will continue to enhance the market outlook.

Growth Factor of the Market

Several factors are contributing to the growth of the bioreactors and fermenters sales market, one of the most significant being the rapid advancements in bioprocessing technologies. As companies invest heavily in research and development, the need for efficient and scalable bioprocessing solutions becomes paramount. Furthermore, the increasing incidence of healthcare concerns and the subsequent rise in biopharmaceutical production is a driving force behind the market's expansion. The food and beverage sector is also shifting towards biotechnological processes for the manufacturing of various products, enhancing the demand for bioreactors and fermenters exponentially. The trend toward sustainability has led to an increased focus on bioprocessing techniques that reduce waste and environmental impact, further augmenting market growth. Key players in the industry are also forming strategic collaborations and partnerships to innovate and improve the efficiency of bioprocessing, thereby creating a dynamic market landscape.

Key Highlights of the Market

• Expected market growth with a CAGR of 10% from 2025 to 2035.
• Increasing demand for biopharmaceuticals as a primary driver for the market.
• Advancements in technology leading to more efficient bioprocessing solutions.
• Sustainability trends encouraging biotechnological processes in food production.
• Strategic collaborations among key players enhancing innovation in bioprocessing technologies.

By Product Type

Stainless Steel Bioreactors:

Stainless steel bioreactors represent a significant segment in the bioreactor and fermenter market due to their robustness and ability to handle high-pressure and high-temperature applications. They are extensively utilized in large-scale biopharmaceutical manufacturing processes, offering excellent durability and longevity. Their design allows for easy maintenance and cleaning, making them an ideal choice for facilities focused on compliance and quality. Moreover, stainless steel bioreactors can be equipped with sophisticated monitoring and control systems that optimize bioprocess efficiencies. The initial investment may be high, but the long-term benefits, such as reduced operational costs and extended life spans, make them a preferred option among manufacturers. As the demand for high-quality biologics continues to rise, the stainless steel bioreactor segment is poised for sustained growth.

Glass Bioreactors:

Glass bioreactors are favored in research and development settings due to their transparency, allowing for real-time observation of the culture conditions. They are particularly useful for small-scale processes and the cultivation of microbial and cell cultures. The ability to sterilize glass bioreactors thoroughly ensures that contamination risks are minimized, which is crucial for experimental precise outputs. Although glass bioreactors are less common in large-scale commercial applications due to fragility and weight limitations, their role in academic and research institutions remains significant. The development of specialized glass bioreactors with better thermal insulation and enhanced features are expected to drive their market growth, particularly in biotechnology research.

Single-Use Bioreactors:

Single-use bioreactors have gained traction due to their flexibility and reduced risk of cross-contamination, making them an attractive option for both small and large-scale operations. Their disposable nature eliminates the need for cleaning and sterilization, drastically reducing downtime between batches. The rapid growth of the biopharmaceutical industry, with an increasing emphasis on personalized medicine, has further accelerated the demand for single-use technologies. Additionally, the ability to easily scale up production without significant capital investment makes single-use bioreactors appealing to manufacturers. The trend is expected to continue as more companies recognize the operational efficiencies and cost-effectiveness associated with single-use bioreactor systems.

Pilot Scale Bioreactors:

Pilot-scale bioreactors serve as an integral bridge between laboratory research and full-scale production. They allow for the precise scaling up of bioprocesses while maintaining the conditions necessary for optimal biological activity. This type of bioreactor is essential for validating processes before moving to large-scale operations, minimizing risks and ensuring regulatory compliance. Industries such as pharmaceuticals, where process optimization is crucial, heavily rely on pilot scale bioreactors. The continuous advancement in bioprocess technologies is likely to fuel growth in this segment, as companies seek to improve their production methodologies and product yield.

Industrial Scale Bioreactors:

Industrial scale bioreactors are designed for mass production of biological products, making them a critical component of the manufacturing process in pharmaceuticals and biotechnology. These bioreactors are capable of accommodating large volumes and are equipped with advanced automation for process control and monitoring. The growing demand for biopharmaceuticals, coupled with the increasing prevalence of chronic diseases, drives the need for industrial-scale production facilities. Additionally, the shift towards continuous manufacturing processes and the emphasis on efficiency will likely enhance the demand for industrial scale bioreactors in the coming years. The ongoing innovations in bioprocessing and equipment reliability are expected to further bolster this segment.

By Application

Pharmaceuticals:

The pharmaceutical sector is the largest application area for bioreactors and fermenters, accounting for a significant portion of the market share. With the increasing prevalence of diseases and rising demand for biologics, the need for effective bioprocessing continues to grow. Bioreactors play an essential role in the production of vaccines, monoclonal antibodies, and recombinant proteins. The stringent regulatory environment necessitates the use of advanced bioreactor technologies that ensure product consistency and quality. As pharmaceutical companies increasingly adopt biotechnological innovations for drug development and manufacturing, the demand for bioreactors tailored for pharmaceutical applications is expected to further escalate.

Biotechnology:

In the biotechnology domain, bioreactors are pivotal for the cultivation of various microorganisms and cell lines for research and production purposes. They support processes such as fermentation and cell culture, which are essential for developing new technologies and products. The emergence of synthetic biology, along with the growing focus on biomanufacturing, is likely to spur demand for bioreactors equipped with high-throughput capabilities. Additionally, collaborations between research institutions and biotech firms are fostering innovation in bioprocessing technologies, further promoting the adoption of bioreactors in this sector. The biotechnology application segment is expected to witness robust growth driven by these factors.

Food & Beverage:

The food and beverage industry is increasingly adopting bioprocessing technologies for the production of fermented products, which is contributing to the growth of the bioreactor market. Bioreactors are integral in producing various items, including alcoholic beverages, dairy products, and plant-based alternatives, by facilitating controlled fermentation processes. As consumer preferences shift towards healthier and sustainable food options, the demand for bioprocessed products is rising. Moreover, the focus on optimizing production processes to enhance yields and reduce waste is driving the adoption of advanced bioreactor technologies in food and beverage applications. This segment is poised for growth, reflecting the overall trend toward biotechnology in food production.

Agriculture:

In agriculture, bioreactors are increasingly employed to produce biofertilizers and biopesticides, enhancing crop yield and minimizing environmental impact. These bioprocessing applications enable the cultivation of beneficial microorganisms that can improve soil health and enhance plant growth. With the rising global population and the need for sustainable agricultural practices, the use of bioreactors in agriculture is gaining traction. Research in microbial production for agricultural applications is on the rise, leading to innovations in bioprocess technology that support efficient cultivation and application. As farmers and agribusinesses look for sustainable solutions, the agricultural application segment of the bioreactor market is expected to grow steadily.

Others:

The "Others" category encompasses various applications that utilize bioreactors and fermenters, including environmental biotechnology, waste treatment, and biofuel production. These applications leverage bioprocessing techniques to transform waste into value-added products and to develop sustainable energy sources. With increasing awareness of environmental sustainability and waste management, the implementation of bioreactors in these fields is becoming more prevalent. Innovations in bioprocessing technology are continually expanding the scope of bioreactors, allowing for novel applications in diverse fields beyond traditional sectors. This segment is expected to contribute to market growth as industries seek more sustainable and efficient production methods.

By Distribution Channel

Direct Sales:

Direct sales channels play a crucial role in the distribution of bioreactors and fermenters, allowing manufacturers to engage directly with customers and understand their specific needs. This approach fosters strong relationships and facilitates tailored solutions that meet unique operational requirements. Direct sales are often favored for high-value equipment like bioreactors, providing customers with the necessary support and expertise during the purchasing process. Moreover, manufacturers can offer personalized training and installation services, enhancing customer satisfaction and loyalty. As bioprocessing continues to evolve, direct sales channels are expected to remain a significant avenue for distributing bioreactors.

Distributor Sales:

Distributor sales represent a vital distribution channel for the bioreactor market, enabling manufacturers to expand their reach and access diverse customer bases. Distributors often have established networks in specific regions, allowing for efficient and effective market penetration. This channel is particularly beneficial for smaller manufacturers who may lack the resources for extensive direct sales operations. Distributors can provide valuable insights into local market trends and customer preferences, ensuring that manufacturers adapt their offerings accordingly. As the demand for bioreactors expands globally, distributor sales are anticipated to grow, facilitating wider access to advanced bioprocessing technologies.

Online Retail:

Online retailing is emerging as an increasingly important distribution channel for bioreactors and fermenters, particularly in light of the digital transformation across industries. This channel provides customers with the convenience of exploring a wide range of products, comparing specifications, and making informed purchasing decisions from the comfort of their offices or labs. Additionally, e-commerce platforms enable manufacturers to reach a broader audience, including start-ups and research institutions that may not have extensive networks. The accessibility of online purchasing is expected to drive sales in the bioreactor market, particularly as technological advancements continue to simplify online transactions and enhance customer experience.

By Technology Type

Single-Use Technology:

Single-use technology is gaining prominence in the bioreactor market due to its significant advantages in reducing contamination risks and operational costs. These bioreactors are designed for one-time use, which eliminates the need for cleaning and sterilization between batches, resulting in shorter turnaround times. This technology is especially beneficial for biopharmaceutical companies that require high flexibility in production volumes and processes. As manufacturers increasingly seek efficiencies in their operations, the adoption of single-use bioreactors is expected to rise. The innovative design and ease of integration with existing systems further contribute to the growing popularity of single-use technology in bioprocessing applications.

Stainless Steel Technology:

Stainless steel technology remains a cornerstone in bioreactor design, especially for large-scale applications requiring durability and reliability. These bioreactors are built to withstand high temperatures and pressures while maintaining stringent cleanliness and quality standards. Their robustness makes them ideal for prolonged use in various bioprocessing environments, particularly in the pharmaceutical sector. Moreover, advancements in stainless steel technology have led to improved design features, such as better thermal control and enhanced process monitoring capabilities. As large-scale production continues to be a focus for many companies, stainless steel bioreactors are expected to maintain their relevance and demand in the market.

Glass Technology:

Glass bioreactors, valued for their transparency, allow researchers to closely monitor and control fermentation processes. They are particularly suited for laboratory settings and small-scale production where visual inspection is essential. The ability to sterilize glass bioreactors thoroughly ensures a reduced risk of contamination, which is crucial for many experiments. Although they are less commonly used in industrial applications, ongoing innovations in glass bioreactor design are aimed at enhancing thermal insulation and minimizing fragility. As research and development in biotechnology expand, glass technology is expected to find a niche market, particularly in academic and experimental settings.

Others:

The "Others" category includes various innovative bioreactor technologies that do not fall into the aforementioned classifications. This segment encompasses hybrid systems that combine the benefits of different technologies, as well as advanced automation and control systems that enhance bioprocess efficiency. As the industry evolves, new technological developments are continuously emerging, providing manufacturers with opportunities to optimize production and reduce costs. The focus on sustainability is driving innovation in bioreactor designs, leading to environmentally friendly and energy-efficient solutions. The diversity of technologies in this category reflects the ongoing advancements in bioprocessing methodologies and the continuous search for innovative solutions in the market.

By Region

The bioreactors and fermenters market is witnessing significant regional growth, with North America leading the charge. The region is expected to account for approximately 40% of the global market share by 2035, driven by the presence of key biopharmaceutical companies and a robust research infrastructure. The increasing investment in bioprocessing technologies and the ongoing push for innovative therapies in the pharmaceutical sector are expected to enhance market dynamics. North America is projected to grow at a CAGR of around 10% during the forecast period, reflecting the high demand for advanced bioreactor systems in drug development and manufacturing processes. The region's focus on biotechnology research and development will continue to propel growth in this market segment.

Europe is also a significant player in the bioreactors and fermenters market, accounting for about 30% of the market share in 2025. The region is characterized by a strong emphasis on biopharmaceutical production and a growing biotechnology sector. The demand for bioprocessing equipment in Europe is driven by stringent regulatory requirements, necessitating the use of advanced bioreactor technologies to ensure compliance and product quality. As European countries increasingly prioritize sustainability and environmental responsibility, the adoption of bioreactors designed for energy-efficient and low-waste processes is likely to gain traction. The European market is expected to maintain steady growth, with a CAGR of approximately 8% over the next decade.

Opportunities

The bioreactors and fermenters market presents numerous opportunities for growth, particularly with the increasing focus on personalized medicine and the development of advanced therapies. As the pharmaceutical industry seeks to enhance the efficiency and scalability of bioprocessing methods, the adoption of innovative bioreactor technologies is likely to rise. Companies that can offer customizable solutions to meet the specific needs of biopharmaceutical manufacturers will have a competitive advantage in the market. Moreover, the rise in biomanufacturing driven by the demand for bio-based products is creating a fertile landscape for manufacturers of bioreactors and fermenters. This focus on sustainability and eco-friendly production processes will lead to increased investment in bioprocessing innovations, further amplifying the growth potential in this market.

Another opportunity lies in the expansion of the bioreactor market in emerging regions, such as Asia Pacific and Latin America. The growing biotechnology sectors in these regions, along with increasing investments in research and development, are expected to drive demand for bioprocessing technologies. As more companies and academic institutions in these regions explore biotechnology applications in pharmaceuticals, agriculture, and food production, the need for advanced bioreactors will escalate. Furthermore, the potential for partnerships and collaborations between local manufacturers and established industry leaders offers a strategic avenue for growth. As these emerging markets develop their capabilities in bioprocessing, they will create new opportunities for bioreactor manufacturers globally.

Threats

Despite the promising outlook for the bioreactors and fermenters market, several threats could hinder growth in the coming years. One of the primary challenges is the high capital investment required for bioreactor technology, which may deter smaller companies and startups from entering the market. The need for continuous innovation and upgrading of bioprocessing systems can also strain financial resources, especially for organizations operating on tight budgets. Additionally, the global supply chain disruptions experienced in recent years have raised concerns around the availability of critical components and raw materials necessary for manufacturing bioreactors. These challenges could create barriers to entry and impede the growth of new players in the market.

Another significant threat to the market is the evolving regulatory landscape, particularly in the biopharmaceutical sector. Companies must navigate complex regulations that mandate stringent quality standards and compliance measures for bioprocessing equipment. Non-compliance can lead to costly penalties, product recalls, and reputational damage. Moreover, technological advancements in bioprocessing may outpace regulatory frameworks, resulting in uncertainty for manufacturers and users. The focus on sustainable and eco-friendly practices is also leading to increased scrutiny of bioprocessing methods, necessitating ongoing adaptation and compliance efforts from industry players. These factors collectively pose challenges that could impede market growth.

Competitor Outlook

• Thermo Fisher Scientific
• Merck KGaA
• GE Healthcare
• Pall Corporation
• Biocon
• Fujifilm Diosynth Biotechnologies
• Lonza Group
• ABEC Inc.
• Eppendorf AG
• Sartorius AG
• Corning Inc.
• Waters Corporation
• Repligen Corporation
• Saint-Gobain
• New England Biolabs

The competitive landscape of the bioreactors and fermenters market is characterized by the presence of numerous key players that offer a wide range of products tailored to various applications. These companies are continuously investing in research and development to innovate and enhance their product offerings. They are adopting strategies such as partnerships, mergers, and acquisitions to strengthen their market position and expand their reach. The focus is on developing advanced technologies that meet the rigorous demands of biopharmaceutical and biotechnology industries, allowing for efficient and scalable production processes. As the market evolves, these organizations are likely to play pivotal roles in shaping the future of bioprocessing technologies.

Thermo Fisher Scientific, a leading player in the bioreactor market, has established a strong reputation for providing innovative solutions that cater to a diverse range of applications. The company's comprehensive portfolio includes single-use bioreactor systems, stainless steel bioreactors, and advanced monitoring technologies that enhance bioprocess efficiencies. With a focus on customer-centric solutions, Thermo Fisher Scientific is well-positioned to capitalize on the growing demand for bioprocessing equipment in pharmaceuticals and biotechnology. The company's commitment to research and development ensures that it stays at the forefront of technological advancements in the industry.

Merck KGaA is another key competitor within the bioreactor space, renowned for its extensive experience in the biopharmaceutical sector. The company offers a wide range of bioreactor technologies, including glass and stainless steel options, while emphasizing sustainability and efficiency in its product designs. Merck KGaA's dedication to developing innovative solutions for bioprocessing has allowed it to maintain a competitive edge in the market. Furthermore, the company's global presence enables it to cater to a diverse customer base, reinforcing its position as a trusted partner in bioreactor and fermenter solutions. As the demand for biopharmaceuticals continues to grow, Merck KGaA is well-equipped to meet the evolving needs of the industry.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 Biocon
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 ABEC Inc.
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Merck KGaA
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 Lonza Group
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 Corning Inc.
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 Eppendorf AG
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Saint-Gobain
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Sartorius AG
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 GE Healthcare
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Pall Corporation
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Waters Corporation
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 New England Biolabs
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 Repligen Corporation
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Thermo Fisher Scientific
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fujifilm Diosynth Biotechnologies
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Bioreactors and Fermenters Sales Market, By Application
    • 6.1.1 Pharmaceuticals
    • 6.1.2 Biotechnology
    • 6.1.3 Food & Beverage
    • 6.1.4 Agriculture
    • 6.1.5 Others
  • 6.2 Bioreactors and Fermenters Sales Market, By Product Type
    • 6.2.1 Stainless Steel Bioreactors
    • 6.2.2 Glass Bioreactors
    • 6.2.3 Single-Use Bioreactors
    • 6.2.4 Pilot Scale Bioreactors
    • 6.2.5 Industrial Scale Bioreactors
  • 6.3 Bioreactors and Fermenters Sales Market, By Technology Type
    • 6.3.1 Single-Use Technology
    • 6.3.2 Stainless Steel Technology
    • 6.3.3 Glass Technology
    • 6.3.4 Others
  • 6.4 Bioreactors and Fermenters Sales Market, By Distribution Channel
    • 6.4.1 Direct Sales
    • 6.4.2 Distributor Sales
    • 6.4.3 Online Retail

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Middle East & Africa - Market Analysis
    • 10.5.1 By Country
      • 10.5.1.1 Middle East
      • 10.5.1.2 Africa
  • 10.6 Bioreactors and Fermenters Sales Market by Region

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Bioreactors and Fermenters Sales market is categorized based on

By Product Type

• Stainless Steel Bioreactors
• Glass Bioreactors
• Single-Use Bioreactors
• Pilot Scale Bioreactors
• Industrial Scale Bioreactors

By Application

• Pharmaceuticals
• Biotechnology
• Food & Beverage
• Agriculture
• Others

By Distribution Channel

• Direct Sales
• Distributor Sales
• Online Retail

By Technology Type

• Single-Use Technology
• Stainless Steel Technology
• Glass Technology
• Others

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Thermo Fisher Scientific
• Merck KGaA
• GE Healthcare
• Pall Corporation
• Biocon
• Fujifilm Diosynth Biotechnologies
• Lonza Group
• ABEC Inc.
• Eppendorf AG
• Sartorius AG
• Corning Inc.
• Waters Corporation
• Repligen Corporation
• Saint-Gobain
• New England Biolabs